| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |